Currently, Cebiotex maintains a strategic alliance with the Catalan pharmaceutical company Prasfarma, a supplier of cell membranes. The biotechnology company uses the facilities of the pharmaceutical company...
Breast cancer is one of the most common cancer types diagnosed in the world. G1 therapeutics drug trilaciclib may help beat it.
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...